Publikationen in Zusammenarbeit mit Forschern von Instituto de Investigaciones Biomédicas Alberto Sols (38)

2024

  1. Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy

    Clinical and Translational Oncology

2023

  1. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

    Science advances, Vol. 9, Núm. 33, pp. eadf6692

  2. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia

    Haematologica, Vol. 108, Núm. 10, pp. 2652-2663

  3. Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice

    Molecular Metabolism, Vol. 74

2022

  1. Pro-vegetarian food patterns and cardiometabolic risk in the PREDIMED-Plus study: a cross-sectional baseline analysis

    European Journal of Nutrition, Vol. 61, Núm. 1, pp. 357-372

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study

    Clinical Nutrition, Vol. 40, Núm. 5, pp. 2825-2836

  3. Validity of the energy-restricted Mediterranean Diet Adherence Screener

    Clinical Nutrition, Vol. 40, Núm. 8, pp. 4971-4979

2020

  1. Dietary polyphenol intake is associated with HDL-cholesterol and a better profile of other components of the metabolic syndrome: A PREDIMED-plus sub-study

    Nutrients, Vol. 12, Núm. 3

  2. MiR-9-5p protects from kidney fibrosis by metabolic reprogramming

    FASEB Journal, Vol. 34, Núm. 1, pp. 410-431

  3. The effect of physical activity and high body mass index on health-related quality of life in individuals with metabolic syndrome

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 10

2019

  1. Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function

    FASEB Journal, Vol. 33, Núm. 8, pp. 9656-9671

2018

  1. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

    Nature Communications, Vol. 9, Núm. 1

  2. CD137 (4-1BB) signalosome: Complexity is a matter of TRAFs

    Frontiers in Immunology, Vol. 9, Núm. NOV

  3. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease

    GLIA, Vol. 66, Núm. 8, pp. 1752-1762

  4. Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)

    OncoImmunology, Vol. 7, Núm. 1

2015

  1. Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression

    BMC Cancer, Vol. 15, Núm. 1

2012

  1. Breast cancer 1 (BrCa1) may be behind decreased lipogenesis in adipose tissue from obese subjects

    PLoS ONE, Vol. 7, Núm. 5

  2. Comments to SEOM clinical guidelines for the treatment of thyroid cancer

    Clinical and Translational Oncology

  3. Differential insulin receptor substrate-1 (IRS1)-related modulation of neuropeptide y and proopiomelanocortin expression in nondiabetic and diabetic IRS2 -/- mice

    Endocrinology, Vol. 153, Núm. 3, pp. 1129-1140